Visionary leaders to drive pioneering research centre
Posted: 20 November 2024 Two esteemed researchers have been appointed to lead the Colonial Foundation Diagnostics Centre, a landmark research centre working to enhance precision diagnosis for inflammatory diseases. The centre, co-led by WEHI and the Royal Melbourne Hospital…
Telix to Add FAP-Targeting Candidates to Theranostic Pipeline
Posted: 20 November 2024 Telix today announces it will expand its theranostic pipeline with new assets targeting Fibroblast Activation Protein (FAP), one of the most promising pan-cancer targets in nuclear medicine. Telix’s development program will initially focus on…
Audit finds Australia’s health and medical researchers are passionate, diverse and highly mobile
Posted: 20 November 2024 We have undertaken a national audit of Australia’s health and medical research workforce. You can now read our findings and learn about opportunities to support our researchers into the future. We carried out the…
New digital project to reveal medical research career opportunities
Posted: 19 November 2024 To increase awareness of the breadth of career pathways available across the health and medical research sector, BioMelbourne Network is kicking-off a one-year project to develop a central portal containing a suite of workforce…
Immutep’s Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer
Posted: 14 November 2024 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces positive data from the investigator-initiated INSIGHT-003 Phase I trial…
Amplia enters into preclinical collaboration with Korean specialist drug screening company Next&Bio
Posted: 14 November 2024 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to announce that it has entered into a research collaboration with Korean preclinical drug screening company Next&Bio. A research collaboration agreement between the…
Clarity and Nucleus RadioPharma sign Master Services Agreement and Cu-67 SAR-bisPSMA Clinical Supply Agreement
Posted: 14 November 2024 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, is pleased to announce it has entered…
World-first cure for lethal skin disease achieved in landmark study
Posted: 14 November 2024 A team of researchers has for the first time cured patients with a lethal skin disease, in a breakthrough study that could lead to an approved curative therapy for the deadly condition. Toxic epidermal…
Project to pioneer alternatives to steroid treatments receives inaugural Translational Bridge Award from Lupus Research Alliance
Posted: 14 November 2024 Associate Professor Sarah Jones from the School of Clinical Sciences at Monash Health is one of five researchers worldwide and the only Australian researcher to receive an inaugural Translational Bridge Award from the Lupus Research Alliance (LRA) in New…
Ancient gene offers new clue to disease susceptibility for First Nations people
Posted: 6 November 2024 A world-first discovery has identified a previously unknown gene variant influencing first-line immune defences in First Nations people – who are at higher risk of severe respiratory viral diseases – and offers insights for…
Mobile white blood cells “gobble up” Alzheimer’s disease plaque
Posted: 6 November 2024 Florey researchers have made a startling discovery: Monocytes, a type of mobile white blood cell, can help clean up plaque-causing amyloid-beta (Aβ) throughout the body. Aβ accumulates in the brains of people with Alzheimer’s…
Revolutionary high-speed 3D bioprinter hailed a gamechanger for drug discovery
Posted: 6 November 2024 Biomedical engineers from the University of Melbourne have invented a 3D printing system, or bioprinter, capable of fabricating structures that closely mimic the diverse tissues in the human body, from soft brain tissue to…
